(Press-News.org) Genetic testing of IVF-created embryos could help more women over 35 have a baby in less time, a clinical trial by researchers from King’s College London, King’s College Hospital, and King’s Fertility has found.
Published today in the Journal of Clinical Medicine, this is the first randomised controlled trial worldwide to focus exclusively on women aged 35–42, a group at higher risk of producing embryos with chromosomal abnormalities. The trial looked at the use of Preimplantation genetic testing for aneuploidy (PGT-A) to check embryos for chromosomal abnormalities before transfer.
Older women are more likely to produce embryos with the wrong number of chromosomes, which can lead to difficulties conceiving, and increases the risk of miscarriage. Current NICE guidance does not currently recommend routine use of PGT-A, driving women to pursue this test privately or skip it altogether. This guidance is based on previous evidence from studies which had a young average age of participants where the rate of aneuploidy, abnormal number of chromosomes in a cell, is lower. The study also broke new ground by including mosaic embryos, those containing both normal and abnormal cells, which are frequently encountered in IVF but rarely included in research.
The pilot study of 100 women undergoing fertility treatment at King’s Fertility was aimed to fill the evidence gap by focusing on older patients, and assessing the feasibility of conducting a multi-centre randomised controlled trial that explores the test’s impact on pregnancy and live birth rates in women aged 35-42. Both the clinical treatment and embryology procedures for the study were carried out at King’s Fertility.
The unblinded trial was conducted from June 2021 to June 2023. There were 50 patients in the PGT-A group and 50 patients in the control group.
The study showed that the PGT-A test showed a higher cumulative live birth rate after up to three embryo transfers with 72% in the PGT-A group versus 52% in the control group.
Women in the PGT-A group achieved pregnancy in fewer transfers, reducing the time to conception, an important factor for women of advanced reproductive age.
Whilst this is a pilot study and the difference did not reach statistical significance due to the small sample size, the trend suggests a potential benefit that warrants investigation in a larger, multi-centre trial.
Dr Yusuf Beebeejaun, first author of the paper at King’s College London and King’s Fertility, said: “The number of women starting their family above the age of 35 is increasing and women in this age group are more likely to create embryos with the wrong number of chromosomes. This increases the risk of unsuccessful implantation and miscarriages. Our findings suggest that targeted use of PGT-A in this age group could help more women have a baby sooner, while also reducing the emotional toll of repeated unsuccessful cycles.”
Lead author Dr Sesh Sunkara from King’s College London and King’s Fertility added: “By focusing exclusively on women aged 35–42 and including mosaic embryos, we have addressed questions that previous studies have not adequately explored. While larger multi-centre trials are needed to confirm these findings, improving treatment efficiency with a shorter time to achieving pregnancy and live birth could reduce the physical and emotional burden of IVF for women of advanced reproductive age.”
Dr Ippokratis Sarris, Director of King’s Fertility and co-author of the study, said: “This research is a testament to the dedication and expertise of the team at King’s Fertility. Not only were all patients recruited and treated here, but the embryology work was also carried out by our laboratory staff. We are proud to have led this pioneering trial, which addresses one of the most important questions in IVF treatment for women over 35, and we look forward to building on these findings in larger, multi-centre studies.”
END
Genetic testing of IVF embryos helps women over 35 conceive faster
2025-08-25
ELSE PRESS RELEASES FROM THIS DATE:
Survey: People not aware knee, groin pain can be signs of hip problems
2025-08-25
COLUMBUS, Ohio – Having a hard time bending over to put your shoes on? Experiencing pain in the knees, groin, thigh or back? A new survey by The Ohio State University Wexner Medical Center reveals many people don’t realize these symptoms can mean there’s a problem in the hip.
The survey of 1,004 people in the United States shows 72% are not aware that knee pain can actually be a sign of a hip problem. Similarly, 69% miss groin pain and 66% miss thigh pain as rooted in the hip.
“Patients will be referred to me for knee pain,” explained Matthew Beal, MD, an orthopedic surgeon at Ohio State Wexner Medical Center. “When I examine the patient, ...
New guideline offers menu of options to help people quit smoking tobacco
2025-08-25
Tobacco smoking is the number one cause of preventable disease and death in Canada; it is highly addictive and hard to stop. Recognizing these challenges, a new guideline from the Canadian Task Force on Preventive Health Care provides a menu of effective options to help people quit smoking, with behavioural and medication options and a natural health product that can be tailored and combined for personal choice. The guideline is published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241584.
“Quitting ...
"Turning spin loss into energy", developing a key technology for ultra-low power next-generation information devices
2025-08-25
Dr. Dong-Soo Han's research team at the Korea Institute of Science and Technology (KIST) Semiconductor Technology Research Center, in collaboration with the research teams of Prof. Jung-Il Hong at DGIST and Prof. Kyung-Hwan Kim at Yonsei University, has developed a device principle that can utilize "spin loss," which was previously thought of as a simple loss, as a new power source for magnetic control.
Spintronics is a technology that utilizes the "spin" property of electrons to store and control information, and it is being recognized as a key foundation for next-generation information processing technologies such as ultra-low-power ...
Evidence, not ideology, must guide preventive health care
2025-08-25
A recent review of the Canadian Task Force on Preventive Health Care underscores the need for expert bodies to produce evidence-based guidance and that Canada should ensure a renewed task force is adequately funded and supported, argues a commentary in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251038.
Dr. Vivek Goel, President and Vice-Chancellor of the University of Waterloo and author of the commentary, chaired the External Expert Review panel that reviewed the task force’s structure, ...
Kids in disadvantaged zip codes face up to 20 times higher odds of gun injuries
2025-08-25
Children residing in “very low-opportunity” neighborhoods are up to 20 times more likely to be hospitalized for gun injuries than those living in the most advantaged areas, reports a new multi-state study published in Pediatrics.
The study also found that most hospitalizations for gun injuries among children under 18 are the result of unintentional shootings — incidents caused by mishandling or accidental discharge of a gun.
“The fewer opportunities a child has in their neighborhood, the greater their odds of ending up in the hospital with a firearm injury,” said co-author Dr. Mehul Raval, Head of Pediatric ...
Gun injury odds up to 20x higher for kids in disadvantaged ZIP codes
2025-08-25
Study analyzed nearly 7,000 pediatric gun injuries and mapped odds by ZIP code
Kids in ‘low-opportunity’ neighborhoods far more likely to be shot than those in ‘high-opportunity’ areas
‘High-opportunity’ kids are far less likely to be shot, but twice as likely to die when it happens
Authors stress urgent need for safe storage and firearm safety education
CHICAGO --- Children residing in “very low-opportunity” neighborhoods are up to 20 times more likely to be hospitalized ...
Younger men have higher risk for mortality and cardiovascular disease for type 2 diabetes than type 1 diabetes; whereas for women type 1 diabetes outcomes are worse at all ages
2025-08-24
The first study of its kind to compare cardiovascular risk in type 1 diabetes (T1D) and type 2 diabetes (T2D) in both men and women shows that younger men with T2D have worse mortality and cardiovascular disease (CVD) outcomes than those with T1D, whereas for women of all ages, almost all outcomes are worse for T1D than for T2D. The study is by Dr Vagia Patsoukaki, Uppsala University, Uppsala, Sweden, and colleagues and is presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September).
CVD is the leading cause of death and morbidity worldwide and individuals with ...
Freeze-framing the cellular world to capture a fleeting moment of cellular activity
2025-08-23
Osaka, Japan – Optical microscopy is a key technique for understanding dynamic biological processes in cells, but observing these high-speed cellular dynamics accurately, at high spatial resolution, has long been a formidable task.
Now, in an article published in Light: Science & Applications, researchers from The University of Osaka, together with collaborating institutions, have unveiled a cryo-optical microscopy technique that take a high-resolution, quantitatively accurate snapshot at a precisely selected timepoint in dynamic ...
Computer hardware advance solves complex optimization problems
2025-08-22
A line of engineering research seeks to develop computers that can tackle a class of challenges called combinatorial optimization problems. These are common in real-world applications such as arranging telecommunications, scheduling, and travel routing to maximize efficiency.
Unfortunately, today’s technologies run into limits for how much processing power can be packed into a computer chip, while training artificial-intelligence models demands tremendous amounts of energy.
Researchers at UCLA and UC Riverside have demonstrated a new approach that overcomes these ...
SOX2: a key player in prostate cancer progression and treatment resistance
2025-08-22
Prostate cancer remains a global health challenge, ranking as the second most common malignancy among men. While early-stage disease can be effectively managed, advanced forms—particularly metastatic castration-resistant prostate cancer (mCRPC)—pose significant therapeutic hurdles. A growing body of evidence highlights the pivotal role of SOX transcription factors, with SOX2 emerging as a central driver in tumor growth, spread, and resistance to therapy.
SOX2 is intricately linked to the fate of cancer stem/progenitor cells, influencing processes ...